Program
Day 2 (May 8, Fri)
09:00-09:40
Plenary Lecture Ⅱ
Sukil Chang (Korea), Amy Klion (USA)
09:00-09:40
Viral Exacerbations of Asthma and COPD: Shared Triggers and Treatments
Sebastian Johnston (UK)
09:40-10:20
Plenary Lecture Ⅲ
Sukil Chang (Korea), Amy Klion (USA)
09:40-10:20
Treatable Traits in Severe Airway Disease: A Personalized Approach to Biologics
Guy Brusselle (Belgium)
10:20-10:40
Coffee Break
13:50-14:30
Plenary Lecture Ⅳ
Byung-Jae Lee (Korea)
13:50-14:30
Unraveling the Heterogeneity of Chronic Urticaria: From Pathogenesis to Precision Medicine
Sarbjit Singh Saini (USA)
10:40-12:10
KAAACI-EAACI Symposium. Precision Approaches in Allergen Immunotherapy: From Evidence to Real-world Practice
Dae Hyun Lim (Korea), Ingrid Terreehorst (Netherlands)
10:40-11:10
Optimising Patient Selection for AIT: Which (Contra) Indications Truly Matter?
Ingrid Terreehorst (Netherlands)
11:10-11:40
Precision Approaches in Allergen Immunotherapy: From Evidence to Real-world Practice
Aspasia Karavelia (Greece)
11:40-12:10
Real-world Evidence of AIT in Korea: Long-term Outcomes and Strategies
Youngsoo Lee (Korea)
12:10-12:20
Break
12:20-13:00
Sponsored Symposium Ⅳ (Sanofi-Aventis Korea)
Yoon-Seok Chang (Korea)
12:20-13:00
Rethinking Asthma Management with Dupilumab: Insights into Airway Remodeling
Alberto Papi (Italy)
13:00-13:50
Break & Poster Discussion Ⅰ
14:50-16:20
Oral Presentation Ⅰ
Kyung Won Kim (Korea), Yoo Seob Shin (Korea)
14:50-15:00Selenomonas Strain LPB0501 Exhibits Anti-Asthmatic Effects Through Cell Wall-Mediated Macrophage ModulationHye Ryun Kang (Korea)
15:00-15:10Mouse Eosinophil-Associated Ribonuclease-2 Contributes to the Promotion of Allergic Airway InflammationNhi Le Thi Kieu (Vietnam)
15:10-15:20The Dynamic Lung Macrophage Landscape: Identifying Myeloid Drivers of VEGF-Induced AngiogenesisHye Ryun Kang (Korea)
15:20-15:30Lipolysis–microlipophagy Cascade Regulated by ATGL Drives Pathogenic Adaptive Type 2 ImmunityHiroyuki Yagyu (Japan)
15:30-15:40Differences in Severe Asthma Phenotypes and Clinical Remission Between Korea and UK in PRISM StudyMinkyo Suh (Korea)
15:40-15:50Pretreatment Blood IL-4/IL-13 Expression as a Biomarker of Dupilumab Response in Severe Asthma: Insights from the PRISM StudyDuong Duc Pham (Korea)
15:50-16:00Asthma Remission in Children: Insights into Associated FactorsSupitchaya Hachai (Thailand)
16:00-16:10Bioinformatics-Driven Identification of a United-Airway Epithelial Transition Program and Molecular Switch Linking Allergic Rhinitis to Comorbid Asthma With Type 2 Endotype EnrichmentRiana Kurniawati (Indonesia)
16:10-16:20Asthma and Functional Dyspepsia: Translational Evidence for IL-33–mediated Airway Neuronal Dysfunction in Neurogenic Lung–gut CrosstalkKeima ITO (Japan)
16:20-16:30
Break
16:30-18:00
KAAACI-AAIAT Symposium. Real-World Perspectives on Allergic and Immunologic Diseases in Asia
Dae Hyun Lim (Korea), Orathai Piboonpocanun (Thailand)
16:30-17:00Adult-onset Immunodeficiency Associated with Anti–interferon-γ Autoantibodies...Wannada Laisuan (Thailand)
17:00-17:30Beyond ω-5 Gliadin: Risk-Stratified Management of Wheat AllergyPunchama Pacharn (Thailand)
17:30-18:00Pediatric Anaphylaxis: Risk Factors and Clinical Phenotypes in AsiaKyunguk Jeong (Korea)
18:00-18:40
Sponsored Symposium Ⅶ (Novartis Korea)
Sae-Hoon Kim (Korea)
18:00-18:40
Inside the Mast Cell: Why Selective BTK Targeting Matters
Jae Hyuk Jang (Korea)
10:40-12:10
KAAACI-Interasma Symposium Ⅰ. Heterogeneity in Severe Asthma: Omics-driven Insights and Evolving Endotypes
Yoon-Seok Chang (Korea), Koichiro Asano (Japan)
10:40-11:10Multi-omics Insights into Eosinophilic Inflammation: Unraveling Novel Pathways in Severe AsthmaKoichi Fukunaga (Japan)
11:10-11:40Asthma-COPD Overlap (ACO): Unraveling the Complexity and Therapeutic StrategiesGuy Brusselle (Belgium)
11:40-12:10Integrated Omics and CT Imaging for Assessing Response to Biologic Therapy in Severe AsthmaJin An (Korea)
12:10-12:20
Break
12:20-13:00
Sponsored Symposium Ⅴ (Celltrion Pharm)
Cheol-Woo Kim (Korea)
12:20-13:00
Introduction of 1st Omalizumab Biosimilar (Omlyclo) and Treatment Strategy for CSU
Adam Reich (Poland)
13:00-13:50
Break & Poster Discussion Ⅰ
14:50-16:20
Oral Presentation Ⅱ
Seon Tae Kim (Korea), Taek Ki Min (Korea)
14:50-15:00Biomass Smoke–exposed Women With Nasal Polyps Demonstrate Epithelial Alarmin Skewing...Nadeem Alam (Nepal)
15:00-15:10Not All Rhinitis Follows the Atopic March: Early-Life Risk Factors Across Three Phenotypes in JECS CohortDaisuke Harama (Japan)
15:10-15:20Geographic Heterogeneity of Eosinophilic Inflammation in Chronic Rhinosinusitis...Liyuan Zhang (China)
15:20-15:30TLR4+ Group 2 Innate Lymphoid Cells Contribute to Persistent Type 2 Immunity in Airway DiseasesZaichuan Wang (China)
15:30-15:40Association of Allergen Signatures With Individualized Allergic PhenotypesDachan Kim (Korea)
15:40-15:50Aryl Hydrocarbon Receptor (AhR) Negatively Regulates the Effector Function of BasophilsKei Nagao (Japan)
15:50-16:00Trends in Allergy Department Visits and Triggers for Pediatric Anaphylaxis in BeijingNannan Jiang (China)
16:00-16:10Time-Dependent Decline in ELISA-Measured Walnut Allergen Levels...Sayaka Hamaguchi (Japan)
16:10-16:20Skin Biophysical and Microbiomic Biomarkers for Development of Eczema in Hong Kong Chinese InfantsTing Fan Leung (Hong Kong)
16:20-16:30
Break
16:30-18:00
Symposium Ⅴ. Updates in Chronic Urticaria: Pathogenesis, Comorbidities, and Treatment Beyond Omalizumab
Sooyoung Lee (Korea), Jeong Hee Choi (Korea)
16:30-17:00The Pathophysiology and Management of Itch in Chronic Urticaria: Beyond HistamineAdam Reich (Poland)
17:00-17:30Beyond Omalizumab: New & Emerging Therapies of CSUMichihiro Hide (Japan)
17:30-18:00Comorbidities in Chronic Spontaneous Urticaria: From Triggers to Systemic ImplicationsYoung-Min Ye (Korea)
18:00-18:40
Sponsored Symposium Ⅷ (Sanofi-Aventis Korea)
Ji-Hun Mo (Korea)
18:00-18:40
Latest Scientific Updates in CRSwNP: Focusing on Type 2 inflammation and Asthma Comorbidity
Hyung-Ju Cho (Korea)
10:40-12:10
Symposium Ⅲ. Allergic Rhinitis and Chronic Rhinosinusitis: Evolving Mechanisms and Targeted Therapeutic Strategies
Sang Min Lee (Korea), Hyunwoo Shin (Korea)
10:40-11:10Novel Insights into the Pathogenesis of Allergic Rhinitis and Chronic RhinosinusitisMin-Seok Rha (Korea)
11:10-11:40Biologics for Allergic Rhinitis and Chronic Rhinosinusitis: Recent UpdatesJin Young Min (Korea)
11:40-12:10Precision Medicine in Allergic Rhinitis and Chronic Rhinosinusitis: Endotypes, Biomarkers, and Treatable TraitsTsuguhisa Nakayama (Japan)
12:10-12:20
Break
12:20-13:00
Sponsored Symposium Ⅵ (GSK Korea)
Heung-Woo Park (Korea)
12:20-13:00
Time to SITT Up and Act for Asthma: Can Single Inhaler Triple Therapy Achieve Clinical Remission in Asthma?
John Oppenheimer (USA)
13:00-13:50
Break & Poster Discussion Ⅰ
14:30-15:30
Allied Health Professional (AHP) Symposium
Sae-Hoon Kim (Korea)
14:30-14:55알레르기 피부시험의 적용과 해석Hyo-In Rhyou (Korea)
14:55-15:20기관지유발검사 방법의 최신지견Sang Min Lee (Korea)
15:20-15:30Break
15:30-16:30
Allied Health Professional (AHP) Symposium
Yong Won Lee (Korea)
15:30-15:55기도염증, 기도저항 평가검사 방법과 실제Sung-Ryeol Kim (Korea)
15:55-16:20약물과민반응 종류에 따른 검사방법Kyung-Min Ahn (Korea)
16:20-16:30Break
16:30-17:20
Allied Health Professional (AHP) Symposium
Hwan Soo Kim (Korea)
16:30-16:55천식, 비염환자 교육의 특급 노하우Hyouk Soo Kwon (Korea)
16:55-17:20아토피피부염 환자 교육의 특급 노하우Jong Soo Hong (Korea)
18:00-18:40
Sponsored Symposium Ⅸ (Lilly Korea)
Jeong Hee Kim (Korea)
18:00-18:40
EBGLYSS 4U: Turn AD Down and Keep It Down
Dong Hun Lee (Korea)
10:40-12:10
Symposium Ⅳ. Artificial Intelligence in Allergy & Immunology: From Fundamentals to Precision Medicine
Yong Mean Park (Korea), Myunghyun Sohn (Korea)
10:40-11:10Deep Learning in Action: Navigating Medical Imaging and Biosignals for Precision DiagnosisNamkug Kim (Korea)
11:10-11:40From Data Quality to Clinical Trust: Practical Insights into Reliable AI in HealthcareSuehyun Lee (Korea)
11:40-12:10Artificial Intelligence in Respiratory Allergy Practice: Current Clinical Applications and Future DirectionsKyungmin Moon (Korea)
12:10-12:20
Break
14:50-16:20
Oral Presentation Ⅲ
Doo-Hee Han (Korea), Gyu-Young Hur (Korea)
14:50-15:00Interpretive Framework for Cough Hypersensitivity Questionnaire Scores in Chronic CoughMinkyo Suh (Korea)
15:00-15:10The Hidden Burden of Chronic Cough: Discordance Between Generic and Cough-Specific Quality-of-Life MeasuresYeonhee Kim (Korea)
15:10-15:20Measurement of Allergen-Specific IgE Using the AdvanSure™ AlloScreen System...Hyun Kyung Oh (Korea)
15:20-15:30Transition to Refractory Chronic Cough: Age-Dependent Role of Cough HypersensitivitySung-Yoon Kang (Korea)
15:30-15:40Association of Granulocyte-Derived Biomarkers With Asthma Severity and Control...Hyun-Seob Jeon (Korea)
15:40-15:50Long-Acting Muscarinic Antagonist as an Alternative to Inhaled Corticosteroids in Type 2-Low Mild Asthma...Noeul Kang (Korea)
15:50-16:00IL-24 May Drive Interferon-Associated Epithelial Responses and Identify Severe Asthma With Increased Exacerbation RiskYoung-Jae Lee (Korea)
16:00-16:10Humoral Immunodeficiency in Severe Asthma: Prevalence and Clinical Significance...Joo-Hee Kim (Korea)
16:10-16:20Staphylococcal Serine Protease-Like Protein D Drives Transcriptomic Changes...Ha-Kyeong Won (Korea)
16:20-16:30
Break
16:30-17:10
Healthcare Policy Directions for Severe Asthma in Korea
JAE WON JEONG (Korea)
16:30-16:45Open PresentationKyoung Hee Sohn (Korea)
16:45-17:10Panel DiscussionSae-Hoon Kim (Korea), Heung-Woo Park (Korea), Jung-min Yoo (Korea), Jinhan Lee (Korea)
17:10-18:40
Public Hearing on Guidelines for Biologics in Severe Asthma
Woo-Jung Song (Korea), Hyun-Jung Kim (Korea)
17:10-18:40Guidelines for Biologics in Severe AsthmaSujeong Kim (Korea)